Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection

Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection

Abstract

Diabetes has become a major public health problem in China nowadays. There are almost 97 million diabetic patients nationwide. Latent autoimmune diabetes in adults (LADA) is a subtype of autoimmune diabetes. Although it has been reported for about 20 years, the diagnostic criteria of this disease remain controversial. The discussion mainly focused on serum autoantibodies, period of insulin need and age of diagnosis. Besides, β cell function, metabolic parameters, genetic factors and cell immunity may also contribute to the formulation of the criteria. Here, we aim to review and discuss the diagnostic criteria of latent autoimmune diabetes in adults.

Keywords

LADA / diagnostic criteria / autoantibodies / insulin independence / age of diagnosis

参考文献

[1] Leslie RD, Williams R, Pozzilli P. Clinical review: type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab2006; 91(5): 1654-1659

[2] Rolandsson O, Palmer JP. Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes! Diabetologia2010; 53(7): 1250-1253

[3] Teng J, Leslie RD. Type 1 diabetes and latent autoimmune diabetes in adults. J Cent S Univ (Med Sci) (Zhong Nan Da Xue Xue Bao Yi Xue Ban)2006; 31(6): 809-813 (in Chinese)

[4] Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia2005; 48(11): 2206-2212

[5] Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J ; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med2010; 362(12): 1090-1101

[6] Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum W, Williams R, Pozzilli P. Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev2008; 24(7): 511-519

[7] Naik RG, Brooks-Worrell BM, Palmer JP. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab2009; 94(12): 4635-4644

[8] Groop L, Tuomi T, Rowley M, Zimmet P, Mackay IR. Latent autoimmune diabetes in adults (LADA)—more than a name. Diabetologia2006; 49(9): 1996-1998

[9] Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TME. Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study. Diabet Med2008; 25(10): 1245-1250

[10] Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes1993; 42(2): 359-362

[11] Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med1994; 11(3): 299-303

[12] Scherbaum WA. Type 1, type 2 diabetes, MODY and LADA. Making a differential diagnosis. MMW Fortschr Med2001; 143(37): 45-48 (in German)

[13] Silva ME. Do we need to diagnosis Latent Autoimmune Diabetes in Adults (LADA)? Arq Bras Endocrinol Metabol2007; 51(1): 8-10 (in Portuguese)

[14] Pan X, Yang W, Xiao J, Chen S. Clinical characteristic and main diagnostic points of latent autoimmune diabetes in adults. Chin J Integr Med (Zhong Hua Nei Ke Za Zhi)1997; 36(3): 159-164 (in Chinese)

[15] Zhou Z. Where is the forward road of LADA study? Chin J Endocrinol Metab (Zhonghua Nei Fen Mi Dai Xie Za Zhi)2005; 21(4): 301-303 (in Chinese)

[16] Zhou Z, Wu H. Diagnosis and treatments of latent autoimmune diabetes in adults. Chin J Endocrinol Metab (Zhonghua Nei Fen Mi Dai Xie Za Zhi)1998; 14(1): 1-2 (in Chinese)

[17] Chi L, Liu X, Li X, Nie B, Li X. The diagnostic criteria of latent autoimmune diabetes of adults. J Chin Physicians (Zhongguo Yi Shi Za Zhi)2006; 8(5): 610-613 (in Chinese)

[18] Li X, Huang G, Yan X, Yang L, Zhou ZG. Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults. J South Med Univ (Nan Fang Yi Ke Da Xue Xue Bao)2010; 30(6): 1247-1249 (in Chinese)

[19] Huang G, Wang X, Li Z, Li H, Li X, Zhou Z. Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese. Acta Diabetol2010<month>May</month><day>16</day>. [Epub ahead of print] DOI: 10.1007/s00592-010-0196-2

[20] Bottazzo GF, Bosi E, Cull CA, Bonifacio E, Locatelli M, Zimmet P, Mackay IR, Holman RR. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia2005; 48(4): 703-708

[21] Dang M, Rockell J, Wagner R, Wenzlau JM, Yu L, Hutton JC, Gottlieb PA, Davidson HW. Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol2011; 186(10): 6056-6063

[22] Li X, Zhou ZG, Huang G, Yan X, Yang L, Chen XY, Wang JP. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes. Ann N Y Acad Sci2004; 1037(1): 122-126

[23] van Deutekom AW, Heine RJ, Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med2008; 25(2):117-125

[24] Weber P, Ambrosova P, Canov P, Weberova D, Kuklinek P, Meluzinova H, Matejovska-Kubesova H, Cejkova P, Bielakova K, Cerna M. GAD antibodies in T1D and LADA—relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles. Adv Gerontol2011; 24(2): 312-318

[25] Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E, Bosi E, Buzzetti R. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: non insulin requiring autoimmune diabetes (NIRAD) 4. Diabetes Care2010; 33(1): 104-108

[26] Yan X, Zhou Z, Huang G, Wang J, Yang L. Optimization of radioligand assays for islet autoantibodies. J Chin Physicians (Zhongguo Yi Shi Za Zhi)2004; 6(6): 731-734 (in Chinese)

[27] Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N, Buzzetti R, Davies H, Leslie D, Williams R. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care2008; 31(3): 439-441

[28] Zhou J, Ma XJ, Bao YQ, Pan XP, Lu W, Hu C, Xiang KS, Jia WP. Study on prevalence of latent autoimmune diabetes in adults and its relationship with metabolic syndrome. Natl Med J China (Zhonghua Yi Xue Za Zhi)2009; 89(18): 1250-1254 (in Chinese)

[29] Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia1999; 42(5): 608-616

[30] Weber P, Meluzínová H, Kubesová H, Ambrosová P, Polcarová V, Cejkova P, Cerna M. Type 1 diabetes and LADA- occurrence of HLA-DRB1*03 and DRB1*04 alleles in two age different groups of diabetics. Adv Gerontol2009; 23(2): 243-248

[31] Yang Z, Wang K, Li T, Sun W, Li Y, Chang YF, Dorman JS, LaPorte RE. Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care1998; 21(4): 525-529

[32] Davies H, Brophy S, Fielding A, Bingley P, Chandler M, Hilldrup I, Brooks C, Williams R. Latent autoimmune diabetes in adults (LADA) in South Wales: incidence and characterization. Diabet Med2008; 25(11): 1354-1357

[33] Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Quality-of-life measures in children and adults with type 1 diabetes. Diabetes Care2010; 33(10): 2175-2177

[34] Yang L, Zhou ZG, Huang G, Yan X. Islet β cell function in latent autoimmune diabetes in adults with islet cell antibodies. J Cent S Univ (Med Sci) (Zhong Nan Da Xue Xue Bao Yi Xue Ban2004; 29(3): 309-314(in Chinese)

[35] Yang L, Zhou ZG, Huang G, Ouyang LL, Li X, Yan X. Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetes. World J Gastroenterol2005; 11(19): 2900-2905

[36] Li X, Zhou Z, Huang G, Su H, Yan X, Yang L. Metabolic syndrome in adult-onset latent autoimmune diabetes. Metab Syndr Relat Disord2005; 3(2): 174-180

[37] Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie RD. Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care2009; 32(1): 160-164

[38] Baum P, Hermann W, Verlohren HJ, Wagner A, Lohmann T, Grahmann F. Diabetic neuropathy in patients with “latent autoimmune diabetes of the adults” (LADA) compared with patients with type 1 and type 2 diabetes. J Neurol2003; 250(6): 682-687

[39] Arikan E, Sabuncu T, Ozer EM, Hatemi H. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with type 2 diabetes mellitus. J Diabetes Complications2005; 19(5): 254-258

[40] Andersen MK, Lundgren V, Turunen JA, Forsblom C, Isomaa B, Groop PH, Groop L, Tuomi T. Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care2010; 33(9): 2062-2064

[41] Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, Bolinder J, Eriksson JW, Gudbjörnsdottir S, Nyström L, Agardh CD, Landin-Olsson M, Sundkvist G, Groop LC. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients. Diabetologia2008; 51(12): 2224-2232

[42] Meierhoff G, Ott PA, Lehmann PV, Schloot NC. Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetes. Diabetes Metab Res Rev2002; 18(5): 367-380

Acknowledgements

This study was supported by the National Natural Science Foundation of China (Grant Nos. 81170725, 81070672, and 81000316); the European Foundation for the Study of Diabetes (Grant No. EFSD/CDS/Lilly-2010); the Key Project of Science and Technology Department of Hunan Province of China (2010SK2007); Hunan Provincial Natural Science Foundation of China (11JJ7005), the National Department Public Benefit (Health) Research Foundation of China (Grant No.201002002).

版权

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg